Trial intelligence / Profile preview

Rectus Sheath Blocks for Abdominal Surgery Relaxation

NCT02447965Terminated

Sponsor
University of Arkansas
Start
Jan 2016
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of bupivacaine in postoperative pain and diastasis recti (RAD), sponsored by University of Arkansas. Primary endpoint: Total consumption of nondepolarizing muscle relaxants. Started Jan 2016; status: terminated.

02

Drugs

bupivacaine
03

Conditions

postoperative paindiastasis recti (RAD)

Beyond the preview

Go deeper on NCT02447965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02447965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call